The Future of Biomarkers.
Biomarker panels
Phenotypes
Precision medicine
Sensitivity
Specificity
Journal
Critical care clinics
ISSN: 1557-8232
Titre abrégé: Crit Care Clin
Pays: United States
ID NLM: 8507720
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
entrez:
18
11
2019
pubmed:
18
11
2019
medline:
9
4
2020
Statut:
ppublish
Résumé
Numerous compounds have been tested as potential biomarkers for multiple possible applications within intensive care medicine but none is or will ever be sufficiently specific or sensitive for the heterogeneous syndromes of critical illness. New technology and access to huge patient databases are providing new biomarker options and the focus is shifting to combinations of several or multiple biomarkers rather than the single markers that research has concentrated on in the past. Biomarkers will increasingly be used as part of routine clinical practice in the future, complementing clinical examination and physician expertise to provide accurate disease diagnosis, prediction of complications, personalized treatment guidance, and prognosis.
Identifiants
pubmed: 31733679
pii: S0749-0704(19)30077-6
doi: 10.1016/j.ccc.2019.08.014
pii:
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
177-187Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.